Publications 2024

Gilhus NE, Andersen H, Andersen LK, Boldingh M, Laakso S, Leopoldsdottir MO, Madsen S, Piehl F, Popperud TH, Punga AR, Schirakow L, Vissing J (2024)
Generalized myasthenia gravis with acetylcholine receptor antibodies: A guidance for treatment
Eur J Neurol, 31 (5), e16229
DOI 10.1111/ene.16229, PubMed 38321574

Nersesjan V, Boldingh MI, Paulsen EQ, Argren M, Høgestøl E, Aamodt AH, Popperud TH, Kondziella D, Jørgensen CS, Jensen VVS, Benros ME (2024)
Antibodies against SARS-CoV-2 spike protein in the cerebrospinal fluid of COVID-19 patients and vaccinated controls: a multicentre study
J Neurol, 272 (1), 60
DOI 10.1007/s00415-024-12769-4, PubMed 39680178

Publications 2023

Rasmussen M, Wallace S, Ørstavik K, Popperud T, Ramm-Pettersen A, Førde R (2023)
[Start and stop criteria for very costly medicines – the example of spinal muscular atrophy]
Tidsskr Nor Laegeforen, 143 (14)
DOI 10.4045/tidsskr.23.0346, PubMed 37830969

Publications 2021

Popperud TH, Gul KA, Brunborg C, Olaussen RW, Abrahamsen TG, Osnes LT, Kerty E (2021)
Thymectomy in Juvenile Myasthenia Gravis Is Safe Regarding Long Term Immunological Effects
Front Neurol, 12, 596859
DOI 10.3389/fneur.2021.596859, PubMed 33716918

Aamodt AH, Høgestøl EA, Popperud TH, Holter JC, Dyrhol-Riise AM, Tonby K, Stiksrud B, Quist-Paulsen E, Berge T, Barratt-Due A, Aukrust P, Heggelund L, Blennow K, Zetterberg H, Harbo HF (2021)
Blood neurofilament light concentration at admittance: a potential prognostic marker in COVID-19
J Neurol, 268 (10), 3574-3583
DOI 10.1007/s00415-021-10517-6, PubMed 33743046

Publications 2020

Broch K, Popperud T, Gude E, Fløisand Y, Antal EA, Bosse G, Jonsrud C, Hegard T, Skaara S, Elsais A (2020)
A Middle-Aged Man Presenting With Progressive Heart Failure, Myopathy, and Monoclonal Gammopathy of Uncertain Significance
JACC Case Rep, 2 (5), 785-789
DOI 10.1016/j.jaccas.2020.02.024, PubMed 34317348

Publications 2019

Allen SM, Bédos Ulvin L, Sabel W, Popperud TH, Ørstavik K (2019)
A painful foot with diagnostic and therapeutic consequences
Scand J Pain, 19 (3), 615-618
DOI 10.1515/sjpain-2019-0015, PubMed 31120861

Publications 2017

Popperud TH, Boldingh MI, Rasmussen M, Kerty E (2017)
Juvenile myasthenia gravis in Norway: Clinical characteristics, treatment, and long-term outcome in a nationwide population-based cohort
Eur J Paediatr Neurol, 21 (5), 707-714
DOI 10.1016/j.ejpn.2017.04.003, PubMed 28457757

Popperud TH, Viken MK, Kerty E, Lie BA (2017)
Juvenile myasthenia gravis in Norway: HLA-DRB1*04:04 is positively associated with prepubertal onset
PLoS One, 12 (10), e0186383
DOI 10.1371/journal.pone.0186383, PubMed 29036181

Publications 2016

Popperud TH, Boldingh MI, Brunborg C, Faiz KW, Heldal AT, Maniaol AH, Müller KI, Rasmussen M, Øymar K, Kerty E (2016)
Juvenile myasthenia gravis in Norway: A nationwide epidemiological study
Eur J Paediatr Neurol, 21 (2), 312-317
DOI 10.1016/j.ejpn.2016.09.001, PubMed 27666466

Publications 2015

Boldingh MI, Maniaol AH, Brunborg C, Dekker L, Heldal AT, Lipka AF, Popperud TH, Niks EH, Verschuuren JJ, Tallaksen CM (2015)
Geographical Distribution of Myasthenia Gravis in Northern Europe--Results from a Population-Based Study from Two Countries
Neuroepidemiology, 44 (4), 221-31
DOI 10.1159/000431036, PubMed 26068011

Publications 2013

Elsais A, Popperud TH, Melien Ø, Kerty E (2013)
[Drugs that may trigger or exacerbate myasthenia gravis]
Tidsskr Nor Laegeforen, 133 (3), 296-9
DOI 10.4045/tidsskr.12.0624, PubMed 23381166

Publications 2012

Jusufovic M, Sandset EC, Popperud TH, Solberg S, Ringstad G, Kerty E (2012)
An unusual case of the syndrome of cervical rib with subclavian artery thrombosis and cerebellar and cerebral infarctions
BMC Neurol, 12, 48
DOI 10.1186/1471-2377-12-48, PubMed 22741548